Recombinant Human TNF-β (E. coli)
Referencia M21057-50ug
embalaje : 50ug
Marca : AbMole Bioscience
All AbMole products are for research use only, cannot be used for human consumption.
LTA; LT; TNFB; TNFSF1
Quality Control & Documentation
Biological Activity
Genus: Human
Expression system: E. coli
Endotoxin: < 0.2 EU/μg of protein by gel coagulation
Purity: >95% by SDS-PAGE analysis
Apparent molecular weight: ~18.6 kDa on SDS-PAGE under reducing conditions
Storage and Stability: This product is stable for up to 6 months at temperatures below -70°C after receipt. After reconstitution, the product should be stable for 1 week at 4°C or for 3 months at -20°C. For long-term storage, the addition of a carrier protein (e.g. 0.1% BSA) is recommended. Avoid repeated freeze-thaw cycles.
Bioactivity: TNF is secreted by macrophages, monocytes, neutrophils, T cells, and NK cells upon stimulation by bacterial LPS. Cells expressing CD4 secrete TNF-α, while CD8 cells secrete little or no TNF-α. TNF-α synthesis is induced by many different stimuli, including interferon, IL2, and GM-CSF. TNF-β is a potent mediator of inflammatory and immune responses. It belongs to the TNF family of ligands and signals through TNFR1 and TNFR2. TNF-β is produced by activated T and B lymphocytes and has similar activity to TNF-α. It mediates a large number of inflammatory, immunostimulatory and antiviral responses.
Chemical Information
Solubility (25°C) | Reconstitute the lyophilized powder in ddH₂O or PBS up to 100 μg/ml. |
Storage | Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
References
[1] Carina C Dos Santos, et al. Vaccines (Basel). Recombinant BCG-LTAK63 Vaccine Candidate for Tuberculosis Induces an Inflammatory Profile in Human Macrophages
[2] Zhenling Ma, et al. Protein J. Expression and purification of recombinant human CCL5 and its biological characterization
[3] Hossein Safarpour, et al. Int J Biol Macromol. Expression analysis and ATR-FTIR characterization of the secondary structure of recombinant human TNF-α from Escherichia coli SHuffle® T7 Express and BL21 (DE3) cells
[4] Andreas Barratt-Due, et al. Mol Immunol. Selective inhibition of TNF-alpha or IL-1 beta does not affect E. coli-induced inflammation in human whole blood
[5] B B Aggarwal, et al. Ciba Found Symp. Human tumour necrosis factors: structure and receptor interactions